February 27, 2020 / 1:16 PM / in a month

REFILE-BRIEF-GSK Says Collaboration Launched To Develop Treatment Regimens For Tuberculosis (Feb. 27)

(Corrects to add dropped word “says” in second bullet) GlaxoSmithKline PLC:

* GSK SAYS GLOBAL COLLABORATION LAUNCHED TO DEVELOP TREATMENT REGIMENS FOR TUBERCULOSIS

* GSK SAYS COLLABORATION AIMS TO ACCELERATE DEVELOPMENT OF NOVEL “PAN-TB” DRUG REGIMENS FOR TREATMENT OF TUBERCULOSIS READY FOR PHASE 3 DEVELOPMENT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below